|
시장보고서
상품코드
2076079
혈장 단백질 치료제 시장 : 제품 유형별, 용도별, 최종 사용자별, 지역별Global Plasma Protein Therapeutic Market, By Product Type, By Application, By End User, By Geography |
||||||
세계의 혈장 단백질 치료제 시장은 2026년에 362억 7,000만 달러 규모에 이를 것으로 추정되고 있어 2033년까지 571억 달러에 이를 것으로 예상되고 있습니다. 2026년부터 2033년까지 CAGR 6.7%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 362억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간 CAGR : | 6.70% | 2033년 시장 규모 예측 : | 571억 달러 |
혈장 단백질 치료제란, 사람의 혈장에서 유래하며 만성 질환을 비롯한 다양한 질환의 치료에 사용되는 치료용 제품을 말합니다. 혈장에는 700유형 이상의 다양한 단백질이 포함되어 있으며, 체내에서 여러 가지 중요한 기능을 수행하고 있습니다. 주요 혈장 단백질 치료제로는 면역글로불린, 응고 인자, 알부민, 그 밖의 특수 단백질 등이 있습니다. 이러한 혈장 유래 제품은 면역 체계 강화, 혈액 응고 및 기타 대사 과정을 촉진하는 데 도움이 됩니다. 만성 질환을 앓고 있는 고령 인구가 증가함에 따라, 전 세계적으로 혈장 유래 치료제에 대한 수요가 높아지고 있습니다. 또한, 첨단 정제 기술을 통해 비용 대비 효과가 높은 방법으로 혈장에서 중요한 단백질을 대량으로 회수할 수 있게 되었습니다.
시장 역학:
세계 혈장 단백질 치료제 시장은 혈장 교환 요법이 필요한 면역 결핍 질환 및 유전성 질환의 유병률 증가에 힘입어 성장하고 있습니다. 출혈성 질환 등 만성 질환에 걸리기 쉬운 고령 인구 증가도 수요를 뒷받침하고 있습니다. 새로운 혈장 유래 제품 개발을 위한 지속적인 연구 개발(R&D) 노력과 의료보험 제도에 따른 적용 범위 확대가 이 분야에 기회를 제공합니다. 그러나 혈장 채취에 관한 엄격한 규제와 혈장 분획 공장에 대한 막대한 설비 투자가 필요하다는 점이 과제로 대두되고 있습니다. 또한, 대체 수단이 될 수 있는 유전자 재조합 치료법의 등장으로 인해 시장 성장이 위협받고 있습니다. 적절하게 선별되지 않은 혈장의 조달과 관련된 안전성 우려도 시장 성장을 저해하고 있습니다.
예를 들어, 2023년 6월 26일 미국 국립생물공학정보센터(NCBI)가 발표한 보고서에 따르면, 2021년 한국의 원발성 면역결핍증(PID) 발생률은 소아 100만 명당 약 11.25건이었습니다. 가장 많이 확인된 면역 결핍은 항체와 관련된 것으로, 53.3%를 차지했으며, 그 다음으로 식균 작용 장애가 28.9%를 차지했습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문에서 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 혈장 단백질 치료제 시장의 주요 기업 프로파일을 소개했습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 세계 혈장 단백질 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 혈장 단백질 치료제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 혈장 단백질 치료제 시장 : 제품 유형별, 2021-2033년
제5장 세계의 혈장 단백질 치료제 시장 : 용도별, 2021-2033년
제6장 세계의 혈장 단백질 치료제 시장 : 최종 사용자별, 2021-2033년
제7장 세계의 혈장 단백질 치료제 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
JHS 26.07.09Global Plasma Protein Therapeutic Market is estimated to be valued at USD 36.27 Bn in 2026 and is expected to reach USD 57.10 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 36.27 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.70% | 2033 Value Projection: | USD 57.10 Bn |
Plasma protein therapeutic refers to therapeutic products that are derived from human blood plasma and are used for treating various medical conditions such as chronic disease and others. Blood plasma contains over 700 different proteins and serves various important functions in the body. Some of the major plasma protein therapeutics include immunoglobulins, coagulation factors, albumin, and other specialty proteins. These plasma derived products help in boosting the immune system, blood clotting, and other metabolic processes. With the growing geriatric population suffering from chronic diseases, there has been a rise in the demand for plasma therapeutics globally. Also, advanced purification technology has enabled significant yield of critical proteins from plasma in a cost-effective manner.
Market Dynamics:
The global plasma protein therapeutic market is driven by the rising prevalence of immune deficiency diseases and genetic disorders requiring plasma replacement therapies. The growing geriatric population prone to chronic illnesses like bleeding disorders is also supporting the demand. Continuous R&D efforts to develop new plasma-derived products and wider coverage under medical insurance schemes are providing opportunities in this space. However, stringent regulations pertaining to plasma collection and high capital requirements for plasma fractionation plants act as challenges. Also, the emergence of alternative recombinant therapies threatens the market growth. Safety concerns around plasma sourcing if not properly screened also hinder the market growth.
For instance, on June 26, 2023, according to a report published by the National Center for Biotechnology Information, in 2021, in South Korea, the occurrence rate of primary immunodeficiencies (PID) stood at around 11.25 cases per million children. The most commonly identified immunodeficiencies were those related to antibodies, constituting 53.3%, with phagocytic disorders trailing at 28.9%.
Key features of the study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global plasma protein therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Octapharma USA Inc., Biotest AG, Kedrion S.p.A, CSL Limited, Grifols, S.A, Takeda Pharmaceutical Company Limited., Octapharma AG, Bio Products Laboratory (BPL), Shire Plc, and Albumedix Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global plasma protein therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasma protein therapeutic market
Global Plasma Protein Therapeutic Market Detailed Segmentation:
- By Product Type (Revenue, USD Bn, 2021 - 2033)
- Albumin
- Immunoglobulin
- Plasma-derived Factor VIII
- Others
- By Application (Revenue, USD Bn, 2021 - 2033)
- Haemophilia
- Primary Immunodeficiency Disorder (PIDD)
- Idiopathic Thrombocytopenic Purpura (ITP)
- Others
- By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Research Laboratories
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Plasma Protein Therapeutic Market:
- Octapharma USA Inc.
- Biotest AG
- Kedrion S.p.A
- CSL Limited
- Grifols, S.A
- Takeda Pharmaceutical Company Limited.
- Octapharma AG
- Bio Products Laboratory (BPL)
- Shire Plc
- Albumedix Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Plasma Protein Therapeutic Market, By Product Type
- Global Plasma Protein Therapeutic Market, By Application
- Global Plasma Protein Therapeutic Market, By End User
- Global Plasma Protein Therapeutic Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing Prevalence of Complement Deficiency Diseases
- High R&D and Production Costs
- Immune Globulin for Various Disease Treatment
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Plasma Protein Therapeutic Market, By Product Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Albumin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Immunoglobulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Plasma-derived Factor VIII
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Plasma Protein Therapeutic Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Haemophilia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Primary Immunodeficiency Disorder (PIDD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Idiopathic Thrombocytopenic Purpura (ITP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Plasma Protein Therapeutic Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Plasma Protein Therapeutic Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2022 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Octapharma USA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biotest AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kedrion S.p.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Grifols, S.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Octapharma AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio Products Laboratory (BPL)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shire Plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Albumedix Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
